Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) EBT Margin (2022 - 2025)

Historic EBT Margin for Dare Bioscience (DARE) over the last 4 years, with Q3 2025 value amounting to 162340.76%.

  • Dare Bioscience's EBT Margin fell 1511120800.0% to 162340.76% in Q3 2025 from the same period last year, while for Sep 2025 it was 30538.58%, marking a year-over-year increase of 317800400.0%. This contributed to the annual value of 239692.2% for FY2024, which is 2385903100.0% down from last year.
  • As of Q3 2025, Dare Bioscience's EBT Margin stood at 162340.76%, which was down 1511120800.0% from 18079.54% recorded in Q2 2025.
  • In the past 5 years, Dare Bioscience's EBT Margin ranged from a high of 18079.54% in Q2 2025 and a low of 162340.76% during Q3 2025
  • In the last 4 years, Dare Bioscience's EBT Margin had a median value of 6034.16% in 2023 and averaged 26491.78%.
  • The largest annual percentage gain for Dare Bioscience's EBT Margin in the last 5 years was 508786600bps (2025), contrasted with its biggest fall of -1511120800bps (2025).
  • Over the past 4 years, Dare Bioscience's EBT Margin (Quarter) stood at 3.84% in 2022, then tumbled by -7543bps to 286.05% in 2023, then soared by 3060bps to 8465.75% in 2024, then crashed by -2018bps to 162340.76% in 2025.
  • Its last three reported values are 162340.76% in Q3 2025, 18079.54% for Q2 2025, and 17927.98% during Q1 2025.